<DOC>
	<DOC>NCT00618709</DOC>
	<brief_summary>The purpose of this research is to evaluate the safety and pharmacokinetic profile of single doses of ATX-101</brief_summary>
	<brief_title>Dose-Escalation Safety and Pharmacokinetic Study of ATX-101</brief_title>
	<detailed_description>This is a single center, open-label, dose-escalation study in which subjects will receive 4 different dosage concentrations (3 dosing paradigms) of ATX-101 in a single dosing session.</detailed_description>
	<criteria>Healthy males or nonpregnant females Age 18 to 65 Sufficient submental fat for injections Signed informed consent Prior interventions in the chin or neck area History or presence of drug or alcohol abuse Treatment with an investigational agent within 30 days before the dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Healthy volunteers</keyword>
</DOC>